Drugmakers file second court challenge to Canada’s new drug price rules
TORONTO (Reuters) – Canada’s main pharmaceutical industry lobby group, along with 16 of its member companies, filed a lawsuit on…
Companies file suit in Canada challenging new rules to lower drug prices
(Reuters) – Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality…
Exclusive: Canada warns U.S. against drug import plans, citing shortage concerns
TORONTO (Reuters) – Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply…
GSK pharma head flags need for speed in high-pressure drug market
LONDON (Reuters) – Doing things one at a time in drug development is not a luxury that GlaxoSmithKline can afford…
Canadian panel calls for universal public drug coverage
OTTAWA/TORONTO (Reuters) – A Canadian advisory council studying prescription drug coverage said on Wednesday the federal government should create a…
British Columbia to be first Canadian province to switch patients to biosimilars
TORONTO/MONTREAL (Reuters) – The Canadian province of British Columbia said on Monday that its public drug plan will switch as…
Italy drugmaker Zambon ready to splash out in U.S., China push
MILAN (Reuters) – Italian drugmaker Zambon is looking to China and the U.S. to grow its respiratory and nervous system…
China to add more cancer drugs to reimbursement list, talks end in Sept: Xinhua
SHANGHAI (Reuters) – China plans to add a range of cancer drugs to medicines eligible for reimbursement from the government,…
Murder Outbreak in London & North Korea Nukes Talk: VICE News Tonight Full Episode (HBO)
This is the May 22, 2018 FULL EPISODE of VICE News Tonight on HBO. 1:57 As part of the preparations…
EU makes it easier for companies to produce generic medicines for export
BRUSSELS (Reuters) – The European Commission on Monday proposed to change intellectual property rules to let pharmaceutical companies produce generic…
FDA chief questions protections on drug rebates, stocks fall
(Reuters) – U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health…
Allergan migraine drug succeeds in second late-stage trial
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50…